Related Experiment Video
Updated: Aug 20, 2026

Assaying Proteasomal Degradation in a Cell-free System in Plants
Published on: March 26, 2014
E1AF degradation by a ubiquitin-proteasome pathway
Akiko Takahashi1, Fumihiro Higashino, Mariko Aoyagi
1Department of Oral Pathobiological Science, Hokkaido University Graduate School of Dental Medicine, North 13 West 7, Kita-ku 060-8586, Sapporo, Japan.
Abstract:
E1AF is a member of the ETS family of transcription factors. In mammary tumors, overexpression of E1AF is associated with tumorigenesis, but E1AF protein has hardly been detected and its degradation mechanism is not yet clear. Here we show that E1AF protein is stabilized by treatment with the 26S protease inhibitor MG132. We found that E1AF was modified by ubiquitin through the C-terminal region and ubiquitinated E1AF aggregated in nuclear dots, and that the inhibition of proteasome-activated transcription from E1AF target promoters. These results suggest that E1AF is degraded via the ubiquitin-proteasome pathway, which has some effect on E1AF function.
Insights
The ETS transcription factor E1AF is degraded through the ubiquitin-proteasome pathway. Inhibiting this pathway stabilizes E1AF protein, impacting its function in mammary tumors.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- E1AF, an ETS family transcription factor, is overexpressed in mammary tumors, correlating with tumorigenesis.
- However, E1AF protein levels are typically low, and its degradation mechanism remains unclear.
Purpose of the Study:
- To investigate the degradation mechanism of E1AF protein.
- To understand the role of the ubiquitin-proteasome pathway in E1AF regulation.
Main Methods:
- Treatment of cells with the 26S protease inhibitor MG132.
- Analysis of E1AF ubiquitination via its C-terminal region.
- Observation of ubiquitinated E1AF localization in nuclear dots.
- Assessment of proteasome inhibition on E1AF target promoter activity.
Main Results:
- MG132 treatment stabilized E1AF protein, indicating proteasomal degradation.
- E1AF undergoes ubiquitination, primarily in its C-terminal region.
- Ubiquitinated E1AF forms aggregates within nuclear dots.
- Inhibition of the proteasome affects E1AF-mediated transcription.
Conclusions:
- E1AF protein is degraded via the ubiquitin-proteasome pathway.
- This degradation mechanism influences E1AF's transcriptional activity and function.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Export of Misfolded Proteins out of the ER
The Unfolded Protein Response
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

